Prasad S. Kulkarni, Abhijit Kadam, Sheela Godbole, Varsha Bhatt, Abhishek Raut, Sunil Kohli, . . . Sugam Salvi. (2023). Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled studyResearch in context. Elsevier.
Chicago Style (17th ed.) CitationPrasad S. Kulkarni, et al. Safety and Immunogenicity of SII-NVX-CoV2373 (COVID-19 Vaccine) in Adults in a Phase 2/3, Observer-blind, Randomised, Controlled StudyResearch in Context. Elsevier, 2023.
MLA (9th ed.) CitationPrasad S. Kulkarni, et al. Safety and Immunogenicity of SII-NVX-CoV2373 (COVID-19 Vaccine) in Adults in a Phase 2/3, Observer-blind, Randomised, Controlled StudyResearch in Context. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.